Understanding how certain enzymes affect RNA modifications in cancer
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
This study is looking at how certain enzymes that change RNA can affect cell function and cancer growth, especially in types like acute myeloid leukemia and glioblastoma, to help us understand how these changes might influence cancer development.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Delaware NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11123142 on NIH RePORTER |
What this research studies
This research investigates the role of specific enzymes called RNA demethylases in regulating RNA modifications that are crucial for cell function and cancer progression. The study aims to uncover the mechanisms by which these enzymes selectively target and modify RNA, particularly in cancers like acute myeloid leukemia and glioblastoma. By developing new tools to monitor these processes in cells, the research seeks to provide insights into how these modifications influence cancer development and progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute myeloid leukemia or glioblastoma who may benefit from novel treatment approaches targeting RNA demethylation.
Not a fit: Patients with cancers not related to acute myeloid leukemia or glioblastoma may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating acute myeloid leukemia and other cancers by targeting RNA modification processes.
How similar studies have performed: While the specific mechanisms of RNA demethylation in cancer are still being explored, there is growing evidence that targeting RNA modifications can be beneficial in cancer treatment, indicating potential for success in this area.
Where this research is happening
Newark, UNITED STATES
- University of Delaware — Newark, United States (Active)
Researchers
- Principal investigator: Mugridge, Jeffrey Scott — University of Delaware
- Study coordinator: Mugridge, Jeffrey Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.